Skip to main content
. 2019 Oct 22;9:1116. doi: 10.3389/fonc.2019.01116

Figure 3.

Figure 3

Kaplan-Meier curve of the PFS2 of all patients receiving 1st PD beyond crizotinib (n = 70), of patients received crizotinib treatment ≥16.0 or <16.0 months.